← Browse by Condition
Medical Condition
severe infection
Total Trials
4
Recruiting Now
4
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for severe infection sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
2 trials
1 trial
1 trial
NCT05788861
Recruiting
Invasive Group A Streptococcal Infection
Enrollment
100 pts
Location
France
Sponsor
Association Clinique Thérapeut...
NCT04923828
Recruiting
Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections
Enrollment
2,000 pts
Location
China
Sponsor
Children's Hospital of Fudan U...
NCT04650607
Recruiting
Phage Safety Cohort Study
Enrollment
100 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06185920
Recruiting
PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
Enrollment
250 pts
Location
France
Sponsor
Hospices Civils de Lyon
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology